titanium has been researched along with everolimus in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 18 (72.00) | 24.3611 |
| 2020's | 7 (28.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baur, HR; Meier, B | 1 |
| Airaksinen, JK; Carlier, M; de Bruyne, B; Debelder, A; Hess, OM; Karjalainen, PP; Lalmand, J; Nammas, W; Niemelä, M; Rivero-Crespo, F; Romppanen, H; Sia, J; Ylitalo, A | 1 |
| Karjalainen, PP; Kervinen, K; Lalmand, J; Mikkelsson, J; Nammas, W; Pentikäinen, M; Pietilä, M; Rivero-Crespo, F; Romppanen, H; Tedjokusumo, P | 1 |
| Airaksinen, JK; Biancari, F; Karjalainen, P; Kiviniemi, TO; Lehtinen, T; Mikkelsson, J; Nammas, W; Pietila, M; Saraste, A; Ylitalo, A | 1 |
| Airaksinen, JK; Debelder, A; Karjalainen, PP; Kervinen, K; Mikkelsson, J; Nammas, W; Pietilä, M; Rivero-Crespo, F; Romppanen, H; Tedjokusumo, P; Ylitalo, A | 1 |
| Díaz-Fernández, J; Doncel-Vecino, LJ; Fernández-Díaz, JA; López-Mínguez, JR; Martínez-Romero, P; Merchán-Herrera, A; Moreu-Burgos, J; Nogales-Asensio, JM; Pomar-Domingo, F; Valdesuso-Aguilar, R | 1 |
| Airaksinen, JK; Biancari, F; Karjalainen, PP; Laine, M; Lalmand, J; Nammas, W; Niemelä, M; Nyman, K; Sia, J; Tedjokusumo, P | 1 |
| Colkesen, EB; Eefting, FD; Karjalainen, PP; Rensing, BJ; Suttorp, MJ; Ten Berg, JM; Van Der Heyden, JA | 1 |
| Airaksinen, JK; Karjalainen, PP; Kiviniemi, TO; Mikkelsson, J; Nammas, W; Perälä, A; Pietilä, M; Romppanen, H; Sia, J; Tuomainen, P; Varho, V | 1 |
| de Belder, A; de Bruyne, B; Karjalainen, PP; Nammas, W; Niemelä, M; Pietilä, M; Rivero-Crespo, F; Sia, J | 1 |
| Airaksinen, JK; de Belder, A; Karjalainen, PP; Kervinen, K; Laine, M; Nammas, W; Romppanen, H; Sia, J | 1 |
| Airaksinen, JKE; de Belder, A; de Bruyne, B; Karjalainen, PP; Kervinen, K; Lalmand, J; Nammas, W; Rivero-Crespo, F; Ylitalo, A | 1 |
| de Belder, A; Karjalainen, PP; Laine, M; Nammas, W; Niemelä, M; Romppanen, H; Sia, J | 1 |
| Ahn, Y; Bae, IH; Hong, YJ; Hyun, DY; Jeong, MH; Kang, JC; Kim, JH; Lee, JH; Lim, KS; Park, DS; Sim, DS; Yang, HY; Zhehao, P | 1 |
| Airaksinen, JK; Karjalainen, PP; Kiviniemi, TO; Nammas, W; Pietilä, M; Romppanen, H; Sia, J; Varho, V | 1 |
| Airaksinen, JK; Karjalainen, PP; Laine, M; Nammas, W; Niemelä, M; Ylitalo, A | 1 |
| Karjalainen, P; Nammas, W; Paana, T; Sia, J; Ylitalo, A | 1 |
| Bae, IH; Hong, YJ; Jang, EJ; Jeong, MH; Kim, HB; Lee, SY; Lim, HC; Lim, KS; Park, DS; Park, JK; Shim, JW; Sim, DS | 1 |
| Airaksinen, JKE; Collet, C; De Bruyne, B; Frambach, P; Karjalainen, PP; Kervinen, K; Lalmand, J; Nammas, W; Penaranda, AS; Pijls, NHJ; Romppanen, H; Sia, J; Tonino, PAL; Van der Heyden, J | 1 |
| Capodanno, D; Monte, MA | 1 |
| Collet, C; De Bruyne, B; Karjalainen, PP; Mizukami, T; Pijls, NHJ; Tonino, PAL | 1 |
| Hamaya, R; Kuno, T; Takahashi, M | 1 |
| Ahn, Y; Cho, KH; Han, X; Hong, YJ; Hyun, DY; Jeong, MH; Kim, J; Kim, JH; Kim, M; Kim, MC; Park, DS; Park, JK; Sim, DS | 1 |
| Collet, C; De Bruyne, B; Karjalainen, PP; Nammas, W; Sia, J | 1 |
| Ahn, Y; Cho, KH; Hong, YJ; Hyun, DY; Jeong, MH; Kim, JH; Kim, M; Kim, MC; Oh, S; Park, DS; Sim, DS | 1 |
15 trial(s) available for titanium and everolimus
| Article | Year |
|---|---|
A prospective randomised comparison of titanium-nitride-oxide-coated bioactive stents with everolimus-eluting stents in acute coronary syndrome: the BASE-ACS trial.
Topics: Acute Coronary Syndrome; Adult; Aged; Angioplasty, Balloon, Coronary; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Sirolimus; Stents; Titanium | 2012 |
Neointimal coverage and vasodilator response to titanium-nitride-oxide-coated bioactive stents and everolimus-eluting stents in patients with acute coronary syndrome: insights from the BASE-ACS trial.
Topics: Acute Coronary Syndrome; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Circulation; Coronary Vessels; Drug-Eluting Stents; Echocardiography, Doppler, Color; Echocardiography, Doppler, Pulsed; Everolimus; Humans; Hyperplasia; Neointima; Percutaneous Coronary Intervention; Predictive Value of Tests; Prospective Studies; Prosthesis Design; Single-Blind Method; Sirolimus; Stents; Time Factors; Titanium; Tomography, Optical Coherence; Treatment Outcome; Vasodilation | 2013 |
Stent-oriented versus patient-oriented outcome in patients undergoing early percutaneous coronary intervention for acute coronary syndrome: 2-year report from the BASE-ACS trial.
Topics: Acute Coronary Syndrome; Aged; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Patient Outcome Assessment; Percutaneous Coronary Intervention; Prospective Studies; Single-Blind Method; Sirolimus; Stents; Titanium; Treatment Outcome | 2013 |
A randomized study to compare bioactive titanium stents and everolimus-eluting stents in diabetic patients (TITANIC XV): 1-year results.
Topics: Aged; Coronary Restenosis; Diabetes Complications; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Sirolimus; Stents; Titanium | 2014 |
Gender-based analysis of randomized comparison of bioactive versus everolimus-eluting stents in acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Antineoplastic Agents; Coronary Angiography; Everolimus; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Propensity Score; Sex Characteristics; Sex Factors; Stents; Titanium; Treatment Outcome | 2015 |
TIDES-ACS Trial: comparison of titanium-nitride-oxide coated bio-active-stent to the drug (everolimus)-eluting stent in acute coronary syndrome. Study design and objectives.
Topics: Acute Coronary Syndrome; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Finland; France; Humans; Netherlands; Prospective Studies; Research Design; Stents; Titanium | 2015 |
Early vascular healing after titanium-nitride-oxide-coated stent versus platinum-chromium everolimus-eluting stent implantation in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Chromium; Coated Materials, Biocompatible; Coronary Vessels; Drug-Eluting Stents; Everolimus; Female; Finland; Fractional Flow Reserve, Myocardial; Humans; Hyperplasia; Male; Microcirculation; Middle Aged; Neointima; Nitric Oxide; Percutaneous Coronary Intervention; Platinum; Prospective Studies; Single-Blind Method; Time Factors; Titanium; Tomography, Optical Coherence; Treatment Outcome; Vascular Resistance; Vasodilator Agents; Wound Healing | 2016 |
4-Year outcome of bioactive stents versus everolimus-eluting stents in acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Antineoplastic Agents; Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Prosthesis Design; Titanium; Treatment Outcome | 2016 |
Long-term outcome of early percutaneous coronary intervention in diabetic patients with acute coronary syndrome: insights from the BASE ACS trial.
Topics: Acute Coronary Syndrome; Aged; Diabetes Complications; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Survival Analysis; Titanium; Treatment Outcome | 2016 |
Long-term clinical outcome of titanium-nitride-oxide-coated stents versus everolimus-eluting stents in acute coronary syndrome: Final report of the BASE ACS trial.
Topics: Acute Coronary Syndrome; Aged; Death; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Prospective Studies; Single-Blind Method; Time Factors; Titanium; Treatment Outcome | 2016 |
Long-term clinical outcome of elderly patients with acute coronary syndrome treated with early percutaneous coronary intervention: Insights from the BASE ACS randomized controlled trial: Bioactive versus everolimus-eluting stents in elderly patients.
Topics: Acute Coronary Syndrome; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Biocompatible Materials; Cardiovascular Diseases; Diabetes Mellitus; Drug-Eluting Stents; Early Medical Intervention; Everolimus; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Percutaneous Coronary Intervention; Recurrence; Single-Blind Method; Stents; Titanium; Treatment Outcome | 2017 |
Comparison of two different sampling intervals for optical coherence tomography evaluation of neointimal healing response after coronary stent implantation.
Topics: Acute Coronary Syndrome; Aged; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neointima; Observer Variation; Percutaneous Coronary Intervention; Prospective Studies; Single-Blind Method; Statistics, Nonparametric; Time Factors; Titanium; Tomography, Optical Coherence; Wound Healing | 2017 |
Optical coherence tomography follow-up 18 months after titanium-nitride-oxide-coated versus everolimus-eluting stent implantation in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Coated Materials, Biocompatible; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Neointima; Titanium; Tomography, Optical Coherence; Treatment Outcome | 2017 |
Titanium-Nitride-Oxide-Coated Versus Everolimus-Eluting Stents in Acute Coronary Syndrome: The Randomized TIDES-ACS Trial.
Topics: Acute Coronary Syndrome; Aged; Cardiovascular Agents; Drug-Eluting Stents; Europe; Everolimus; Female; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Prosthesis Design; Time Factors; Titanium; Treatment Outcome | 2020 |
Comparative study of neointimal coverage between titanium-nitric oxide-coated and everolimus-eluting stents in acute coronary syndromes.
Topics: Acute Coronary Syndrome; Chromium; Coronary Vessels; Drug-Eluting Stents; Everolimus; Humans; Nitric Oxide; Percutaneous Coronary Intervention; Sirolimus; Titanium; Tomography, Optical Coherence; Treatment Outcome | 2023 |
10 other study(ies) available for titanium and everolimus
| Article | Year |
|---|---|
The Titan stent, just a good bare metal stent or more?
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Sirolimus; Stents; Titanium | 2012 |
Outcome of ST-elevation myocardial infarction versus non-ST-elevation acute coronary syndrome treated with titanium-nitride-oxide-coated versus everolimus-eluting stents: insights from the BASE-ACS trial.
Topics: Acute Coronary Syndrome; Aged; Anticoagulants; Coated Materials, Biocompatible; Combined Modality Therapy; Coronary Restenosis; Disease-Free Survival; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Heart Diseases; Humans; Incidence; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Myocardial Ischemia; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Randomized Controlled Trials as Topic; Sirolimus; Titanium; Treatment Outcome | 2013 |
A novel polymer-free drug-eluting stent coated with everolimus using nitrogen-doped titanium dioxide film deposition in a porcine coronary restenosis model.
Topics: Animals; Coronary Restenosis; Disease Models, Animal; Drug-Eluting Stents; Everolimus; Nitrogen; Polymers; Prosthesis Design; Random Allocation; Swine; Titanium | 2016 |
Usefulness of Post-coronary Dilation to Prevent Recurrent Myocardial Infarction in Patients Treated With Percutaneous Coronary Intervention for Acute Coronary Syndrome (from the BASE ACS Trial).
Topics: Acute Coronary Syndrome; Aged; Antineoplastic Agents; Case-Control Studies; Coronary Restenosis; Dilatation; Drug-Eluting Stents; Everolimus; Female; Heart Diseases; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Percutaneous Coronary Intervention; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Secondary Prevention; Stents; Titanium | 2017 |
In vitro and in vivo evaluation of a novel polymer-free everolimus-eluting stent by nitrogen-doped titanium dioxide film deposition.
Topics: Animals; Cell Proliferation; Coronary Restenosis; Disease Models, Animal; Drug-Eluting Stents; Everolimus; Myocytes, Smooth Muscle; Nitrogen; Platelet Adhesiveness; Platelet Aggregation; Polymers; Spectroscopy, Fourier Transform Infrared; Surface Properties; Sus scrofa; Titanium; Tomography, Optical Coherence | 2018 |
Stent Wars: Coated Stents Strike Back.
Topics: Acute Coronary Syndrome; Drug-Eluting Stents; Everolimus; Humans; Stents; Titanium; Treatment Outcome | 2020 |
Reply: The Randomized TIDES-ACS Trial.
Topics: Acute Coronary Syndrome; Drug-Eluting Stents; Everolimus; Humans; Stents; Titanium; Treatment Outcome | 2020 |
The Randomized TIDES-ACS Trial.
Topics: Acute Coronary Syndrome; Drug-Eluting Stents; Everolimus; Humans; Stents; Titanium; Treatment Outcome | 2020 |
Preclinical Evaluation of a Novel Polymer-free Everolimus-eluting Stent in a Mid-term Porcine Coronary Restenosis Model.
Topics: Animals; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Disease Models, Animal; Drug Evaluation, Preclinical; Drug-Eluting Stents; Everolimus; Polymers; Swine; Swine, Miniature; Titanium; Tomography, Optical Coherence | 2021 |
Successful implantation of a novel polymer-free everolimus-eluting stent using nitrogen-doped titanium dioxide film with good patency on follow-up angiography: A case report.
Topics: Coronary Angiography; Coronary Vessels; Drug-Eluting Stents; Everolimus; Follow-Up Studies; Humans; Male; Middle Aged; Nitrogen; Nitrogen Dioxide; Percutaneous Coronary Intervention; Polymers; Titanium; Tomography, Optical Coherence; Treatment Outcome | 2022 |